title: New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis
authors.initials: G
authors.lastname: Bold
authors.initials: KH
authors.lastname: Altmann
authors.initials: J
authors.lastname: Frei
authors.initials: M
authors.lastname: Lang
authors.initials: PW
authors.lastname: Manley
authors.initials: P
authors.lastname: Traxler
authors.initials: B
authors.lastname: Wietfeld
authors.initials: J
authors.lastname: Bruggen
authors.initials: E
authors.lastname: Buchdunger
authors.initials: R
authors.lastname: Cozens
authors.initials: S
authors.lastname: Ferrari
authors.initials: P
authors.lastname: Furet
authors.initials: F
authors.lastname: Hofmann
authors.initials: G
authors.lastname: Martiny-Baron
authors.initials: J
authors.lastname: Mestan
authors.initials: J
authors.lastname: Rosel
authors.initials: M
authors.lastname: Sills
authors.initials: D
authors.lastname: Stover
authors.initials: F
authors.lastname: Acemoglu
authors.initials: E
authors.lastname: Boss
authors.initials: R
authors.lastname: Emmenegger
authors.initials: L
authors.lastname: Lasser
authors.initials: E
authors.lastname: Masso
authors.initials: R
authors.lastname: Roth
authors.initials: C
authors.lastname: Schlachter
authors.initials: W
authors.lastname: Vetterli